1. Home
  2. ACRS vs HVT Comparison

ACRS vs HVT Comparison

Compare ACRS & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

529.9M

Sector

Health Care

ML Signal

HOLD

Logo Haverty Furniture Companies Inc.

HVT

Haverty Furniture Companies Inc.

HOLD

Current Price

$29.31

Market Cap

435.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRS
HVT
Founded
2012
1885
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
529.9M
435.8M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
ACRS
HVT
Price
$3.77
$29.31
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $10.18
N/A
AVG Volume (30 Days)
★ 3.5M
82.1K
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
★ 4.42%
EPS Growth
★ 69.01
N/A
EPS
N/A
★ 0.77
Revenue
$1,683,000.00
★ $758,995,000.00
Revenue This Year
N/A
$5.99
Revenue Next Year
N/A
$7.90
P/E Ratio
★ N/A
$38.75
Revenue Growth
N/A
★ 4.99
52 Week Low
$2.10
$20.06
52 Week High
$6.60
$29.84

Technical Indicators

Market Signals
Indicator
ACRS
HVT
Relative Strength Index (RSI) 39.97 64.20
Support Level $3.18 $26.93
Resistance Level $3.86 $29.83
Average True Range (ATR) 0.31 0.58
MACD 0.07 0.19
Stochastic Oscillator 54.05 81.79

Price Performance

Historical Comparison
ACRS
HVT

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.

Share on Social Networks: